We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.74%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.79B
AUM Growth
+$1.29B
(+24%)
Cap. Flow
+$933M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
15.83%
Holding
1,205
New
433
Increased
209
Reduced
253
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lazard
LAZ
|
+$67.3M |
| 2 |
PPG Industries
PPG
|
+$49.7M |
| 3 |
Apple
AAPL
|
+$46.8M |
| 4 |
Micron Technology
MU
|
+$42.1M |
| 5 |
H&R Block
HRB
|
+$41.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$54.9M |
| 2 |
Blackstone
BX
|
+$36.2M |
| 3 |
SNDK
SANDISK CORP
SNDK
|
+$35.8M |
| 4 |
International Flavors & Fragrances
IFF
|
+$34.2M |
| 5 |
KKR & Co
KKR
|
+$33.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.8% |
| 2 | Communication Services | 12.26% |
| 3 | Healthcare | 12.21% |
| 4 | Materials | 11.4% |
| 5 | Financials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Emergent Biosolutions
EBS
$375M
| $3.2M | 0.05% |
+142,650
| New | +$3.32M |
|
|
BNY
327
Bank of New York Mellon
BNY
$108B
| $3.2M | 0.05% |
+85,397
| New | +$2.95M |
|
328
VanEck Gold Miners ETF
GDX
$23B
| $3.19M | 0.05% |
120,667
+17,916
| +17% | +$430K |
|
329
Copa Holdings
CPA
$5.56B
| $3.14M | 0.05% |
22,053
-38,189
| -63% | -$5.35M |
|
|
CODE
330
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $3.14M | 0.05% |
149,072
+91,861
| +161% | +$1.74M |
|
331
Robert Half
RHI
$3.61B
| $3.1M | 0.05% |
64,956
+57,405
| +760% | +$2.57M |
|
332
LPL Financial
LPLA
$26.3B
| $3.03M | 0.04% |
60,864
+52,632
| +639% | +$2.55M |
|
|
MHR
333
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $3.02M | 0.04% |
368,470
-66,325
| -15% | -$540K |
|
334
Palo Alto Networks
PANW
$264B
| $3.02M | 0.04% |
216,186
-336,564
| -61% | -$3.93M |
|
335
American Electric Power
AEP
$73.7B
| $3.02M | 0.04% |
54,135
+47,776
| +751% | +$2.52M |
|
336
Ralph Lauren
RL
$22.2B
| $3M | 0.04% |
18,677
-10,359
| -36% | -$1.6M |
|
337
Philip Morris
PM
$301B
| $2.92M | 0.04% |
34,672
-22,273
| -39% | -$1.92M |
|
|
BDSI
338
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.88M | 0.04% |
+238,807
| New | +$2.26M |
|
339
Occidental Petroleum
OXY
$57B
| $2.88M | 0.04% |
29,260
-327,619
| -92% | -$30.8M |
|
|
FNGN
340
DELISTED
Financial Engines, Inc.
FNGN
| $2.82M | 0.04% |
+62,337
| New | +$2.79M |
|
341
Barrett Business Services
BBSI
$976M
| $2.81M | 0.04% |
239,152
+56,408
| +31% | +$714K |
|
|
NPKI
342
NPK International
NPKI
$1.21B
| $2.81M | 0.04% |
225,310
+48,674
| +28% | +$568K |
|
343
Maximus
MMS
$3.14B
| $2.79M | 0.04% |
64,884
-269,269
| -81% | -$11.6M |
|
344
BioCryst Pharmaceuticals
BCRX
$2.37B
| $2.79M | 0.04% |
+218,413
| New | +$2.12M |
|
|
WMGI
345
DELISTED
Wright Medical Group Inc
WMGI
| $2.77M | 0.04% |
+88,379
| New | +$2.64M |
|
|
SALE
346
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $2.77M | 0.04% |
+104,297
| New | +$3.03M |
|
|
RDA
347
DELISTED
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
| $2.75M | 0.04% |
160,936
+32,361
| +25% | +$554K |
|
|
NORD
348
DELISTED
Nord Anglia Education, Inc.
NORD
| $2.75M | 0.04% |
+150,000
| New | +$2.77M |
|
|
TESO
349
DELISTED
Tesco Corp
TESO
| $2.73M | 0.04% |
+127,802
| New | +$2.62M |
|
|
ASRT
350
DELISTED
Assertio
ASRT
| $2.71M | 0.04% |
+3,244
| New | +$2.5M |
|
Similar funds
Marshall Wace's Q2 2014 Portfolio in Review
As of Q2 2014, Marshall Wace held 1,205 positions worth $6.79B, up 24% from $5.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $933M of net new capital in Q2 2014, opening 433 new positions and adding to 209 existing holdings. Its largest new stake was H&R Block: 1,400,000 shares worth $46.9M.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was SANDISK CORP, an estimated $35.8M trimmed.
- Marshall Wace's largest Q2 2014 buy was H&R Block: 1,400,000 shares worth $46.9M.
- Marshall Wace added most to Lazard in Q2 2014, an estimated $67.3M increase.
- Marshall Wace's biggest Q2 2014 reduction was SANDISK CORP, cutting an estimated $35.8M.
- Marshall Wace fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q2 2014, selling an estimated $54.9M.
- Marshall Wace's ten largest holdings make up 16% of its $6.79B portfolio in Q2 2014.
- Marshall Wace opened 433 new positions and closed 295 in Q2 2014.
- Marshall Wace's portfolio value rose 24% quarter-over-quarter to $6.79B.
Based on Marshall Wace's 13F filing for Q2 2014, filed 14 Aug 2014.